198 related articles for article (PubMed ID: 38455648)
1. Unveiling the pathogenesis and therapeutic approaches for diabetic nephropathy: insights from panvascular diseases.
Zhang X; Zhang J; Ren Y; Sun R; Zhai X
Front Endocrinol (Lausanne); 2024; 15():1368481. PubMed ID: 38455648
[TBL] [Abstract][Full Text] [Related]
2. Diabetic nephropathy and multiorgan protection. Part II.
Gluhovschi G; Gluhovschi C; Vlad A; Timar R; Bob F; Velciov S; Bozdog G; Petrica L
Rom J Intern Med; 2011; 49(4):237-49. PubMed ID: 22568268
[TBL] [Abstract][Full Text] [Related]
3. Diabetic Nephropathy: a Tangled Web to Unweave.
Magee C; Grieve DJ; Watson CJ; Brazil DP
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):579-592. PubMed ID: 28956186
[TBL] [Abstract][Full Text] [Related]
4. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms.
Gnudi L; Coward RJM; Long DA
Trends Endocrinol Metab; 2016 Nov; 27(11):820-830. PubMed ID: 27470431
[TBL] [Abstract][Full Text] [Related]
5. Improvements in the Management of Diabetic Nephropathy.
Dounousi E; Duni A; Leivaditis K; Vaios V; Eleftheriadis T; Liakopoulos V
Rev Diabet Stud; 2015; 12(1-2):119-33. PubMed ID: 26676665
[TBL] [Abstract][Full Text] [Related]
6. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms.
Tonna S; El-Osta A; Cooper ME; Tikellis C
Nat Rev Nephrol; 2010 Jun; 6(6):332-41. PubMed ID: 20421885
[TBL] [Abstract][Full Text] [Related]
7. Overview of the safety, efficiency, and potential mechanisms of finerenone for diabetic kidney diseases.
Chen W; Zheng L; Wang J; Lin Y; Zhou T
Front Endocrinol (Lausanne); 2023; 14():1320603. PubMed ID: 38174337
[TBL] [Abstract][Full Text] [Related]
8. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD.
Mottl AK; Nicholas SB
Am J Kidney Dis; 2024 Mar; 83(3):277-287. PubMed ID: 38142396
[TBL] [Abstract][Full Text] [Related]
9. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2024.
American Diabetes Association Professional Practice Committee
Diabetes Care; 2024 Jan; 47(Suppl 1):S219-S230. PubMed ID: 38078574
[TBL] [Abstract][Full Text] [Related]
10. Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop.
Ceriello A; Rodbard HW; Battelino T; Brosius F; Cosentino F; Green J; Ji L; Kellerer M; Koob S; Kosiborod M; Lalic N; Marx N; Nedungadi TP; Parkin CG; Rydén L; Sheu WH; Standl E; Vandvik PO; Schnell O;
Cardiovasc Diabetol; 2023 Oct; 22(1):277. PubMed ID: 37833776
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol prevents Drp1-mediated mitochondrial fission in the diabetic kidney through the PDE4D/PKA pathway.
Zhu X; Deng Z; Cao Y; Zhou Z; Sun W; Liu C; Fan S; Yin XX
Phytother Res; 2023 Dec; 37(12):5916-5931. PubMed ID: 37767771
[TBL] [Abstract][Full Text] [Related]
12. NETosis: an emerging therapeutic target in renal diseases.
Juha M; Molnár A; Jakus Z; Ledó N
Front Immunol; 2023; 14():1253667. PubMed ID: 37744367
[TBL] [Abstract][Full Text] [Related]
13. The progression from mild to severe hyperglycemia coupled with insulin resistance causes mitochondrial dysfunction and alters the metabolic secretome of epithelial kidney cells.
Braga PC; Bernardino RL; Guerra-Carvalho B; Carrageta DF; Oliveira PF; Rodrigues AS; Alves MG
Exp Cell Res; 2023 Oct; 431(2):113744. PubMed ID: 37648074
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
